Novartis Announces Spin-Off of Alcon Eye Care Business on April 9, 2019

Published: March 22, 2019 | Tags: Novartis, Announces, Spin-Off, Alcon, Eye Care, Business, April 9, 2019

Celgene Collaborates with Exscientia for its AI Drug Discovery Platform

Published: March 22, 2019 | Tags: Celgene, Collaborates, Exscientia, AI, Drug Discovery Platform

Biogen and Eisai Terminate P-III ENGAGE and EMERGE Study for Alzheimer’s Disease

Published: March 22, 2019 | Tags: Biogen, Eisai, Terminate, P-III, ENGAGE, EMERGE, Study, Alzheimer’s Disease

?Merck Extends its Strategic Collaboration with NGM Biopharmaceuticals

 Published: March 22, 2019 | Tags: Merck, Extends, Development, Commercializing, Agreement, NGM, Novel, Biologic, Therapeutics

?Jazz Pharmaceuticals’ Sunosi (solriamfetol) Receives FDA’s Approval for the Treatment of Sleep Disorders

Published: March 22, 2019 | Tags: Jazz Pharmaceuticals, Sunosi, solriamfetol, Receives, FDA, Approval, Treatment, Sleep Disorders

?AbbVie Reports FDA’s Hold on All Clinical Trials Evaluating Venclexta/Venclyxto (venetoclax) for Multiple Myeloma

Published: March 20, 2019 | Tags: AbbVie, Announces, FDA, Hold, Venclexta/Venclyxto, venetoclax, P-III, BELLINI, Study, Multiple Myeloma

Merck KGaA Collaborates with GenScript for the Expansion of Cell and Gene Therapies in China

Published: March 20, 2019 |Tags: Merck KGaA, Collaborates, GenScript, Expand, Cell, Gene Therapies, China

?Evotec and GARDP Collaborates to Develop Novel Antibiotics for Antimicrobial Resistance (AMR)

Published: March 20, 2019 | Tags: Evotec, GARDP, Collaborates, Develop, Novel, Antibiotics, Antimicrobial Resistance, AMR

Sage Therapeutics’ Zulresso (brexanolone) Receives FDA’s Approval for Postpartum Depression (PPD)

Published: March 20, 2019 | Tags: Sage Therapeutics, Zulresso, brexanolone, Receives, FDA, Approval, Postpartum Depression, PPD

Merck KGaA and Pfizer Terminates P-III JAVELIN Ovarian PARP 100 Study for Advanced Ovarian Cancer

Published: March 20, 2019 | Tags: Merck KGaA, Pfizer, Terminates, P-III, JAVELIN Ovarian PARP 100, Study, Advanced Ovarian Cancer

?Thea Signs a License Agreement with OliX to Develop RNAi Therapies (OLX301A) for Age-Related Macular Degeneration (AMD)

Published:  March 19, 2019 | Tags: Thea, Signs, License, Agreement, OliX, Develop, RNAi Therapies, OLX301A, Age-Related Macular Degeneration, AMD

Roche’s Tecentriq (atezolizumab) + Chemotherapy (carboplatin and etoposide) Receive FDA’s Approval for Extensive-Stage Small Cell Lung Cancer (ES-SCLC)  

Published: March 19, 2019 | Tags: Roche, Tecentriq, Chemotherapy, Carboplatin, Etoposide, Receive, FDA, Approval, ES-SCLC

Mylan Voluntary Globally Recalls 2 Lots of Levoleucovorin (250mg/25ml) Injection Used to Prevent Harmful Effects of Methotrexate

Published: March 19, 2019 | Tags: Akebia Therapeutics, Reports, Positive, Results, Vadadustat, P-III, J01, J03, Studies, Anemia, Chronic Kidney Disease, CKD, Japan

Baxter and BioMerieux Collaborates to Develop Biomarkers for Acute Kidney Injury (AKI)

Published: March 19, 2019 | Tags: Baxter, BioMerieux, Collaborates, Develop, Biomarkers, Acute Kidney Injury, AKI

AstraZeneca Reports Positive Results of Farxiga in P-III DECLARE-TIMI 58 Study for Type-2 Diabetes (T2D)

Published: March 19, 2019 | Tags: ? AstraZeneca, Reports, Positive, Results, Farxiga, P-III, DECLARE-TIMI 58, Study, Type-2 Diabetes

?Cellesce Signs a License Agreement with Hubrecht Organoid Technology (HUB) for the Expansion of Organoids

Published: March 18, 2019 | Tags: Cellesce, Signs, License, Agreement, Hubrecht Organoid Technology, HUB, Expansion, Organoids

?Novartis Reports Results of Entresto (sacubitril/valsartan) in PIONEER-HF 4-Week Extension Study for Systolic Heart Failure

Published: March 18, 2019 | Tags: Novartis, Reports, Results, Entresto, sacubitril/valsartan, PIONEER-HF, 4-Week, Extension, Study, Systolic Heart Failure

Alcon to Acquire PowerVision for $285M

Published: March 18, 2019 | Tags: Novartis, Alcon, Acquire, PowerVision, $285M

BMS Reports Positive Results of Eliquis (apixaban) in P-IV AUGUSTUS Study for NVAF/ACS/PCI

Published: March 18, 2019 | Tags: BMS, Reports, Positive, Results, Eliquis, apixaban, P-IV, AUGUSTUS, Study, NVAF/ACS/PCI